CA19-9 epitope a possible marker for MUC-1/Y protein

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MUC-1 molecules lacking tandem repeats (MUC-1/Y) are found in carcinoma cells and linked to progression.
• The clinical significance of MUC-1/Y remains unclear.
• DF3 and CA19-9 epitopes are MUC-1-related tumor-associated antigens implicated in cancer prognosis.

Purpose of the Study:

• To investigate the expression of DF3 and CA19-9 epitopes on MUC-1 variants.
• To determine if CA19-9 is a specific marker for MUC-1/Y protein.

Main Methods:

• Constructed mouse colon adenocarcinoma cell lines (MC-38) expressing either MUC-1/Y (Y-MC-38) or MUC-1/R (R-MC-38).
• Utilized RT-PCR to detect MUC-1/Y mRNA.
• Employed Fluorescence-activated cell sorting (FACS) and Western blot analysis with monoclonal antibodies against DF3 and CA19-9 epitopes.
• Analyzed MUC-1/Y mRNA expression in human cancer cell lines.

Main Results:

• Y-MC-38 cells expressed CA19-9 but not DF3, while R-MC-38 cells expressed DF3 but not CA19-9.
• Western blot identified a 40 kDa protein recognized by anti-CA19-9 in Y-MC-38 cells and a 70 kDa protein recognized by anti-DF3 in R-MC-38 cells.
• Human cancer cell lines HT-29 and Capan-1 showed MUC-1/Y mRNA and CA19-9 expression.

Conclusions:

• The CA19-9 epitope is exclusively produced on the MUC-1/Y core protein.
• CA19-9 may function as a specific biomarker for MUC-1/Y protein in various human cancers.